| Metric | 03/15/2026 | 12/10/2025 | 09/05/2025 | 06/18/2025 | Trend |
|---|---|---|---|---|---|
| BP (mmHg) | 148/92 | 152/94 | 144/90 | 138/86 | 📈 Worsening |
| HR (bpm) | 78 | 74 | 76 | 72 | ➡ Stable |
| Weight (lbs) | 178 | 176 | 175 | 173 | 📈 +5 lbs / yr |
| BMI | 30.6 | 30.3 | 30.1 | 29.7 | 📈 Trending up |
| SpO2 (%) | 97 | 98 | 97 | 98 | ✓ Normal |
| Order | Priority | Ordered By | Date / Time | Status |
|---|---|---|---|---|
| HbA1c (Glycosylated Hemoglobin) | Routine | Dr. J. Carter | 03/15/2026 9:38 AM | Pending |
| Comprehensive Metabolic Panel (CMP) | Routine | Dr. J. Carter | 03/15/2026 9:38 AM | Pending |
| Lipid Panel (fasting) | Routine | Dr. J. Carter | 03/15/2026 9:38 AM | Pending |
| Urine Microalbumin / Creatinine Ratio | Routine | Dr. J. Carter | 03/15/2026 9:38 AM | Pending |
| CBC with Differential | Routine | Dr. J. Carter | 12/10/2025 10:05 AM | Resulted |
| TSH (Thyroid Stimulating Hormone) | Routine | Dr. J. Carter | 09/05/2025 11:20 AM | Resulted |
| Medication | Change | Sig | Qty / Refills | Status |
|---|---|---|---|---|
| Lisinopril | Dose ↑ 10 mg → 20 mg | 1 tab PO QD | 30 tabs · 3 refills | Sent to Pharmacy |
| Amlodipine 5 mg | New Start | 1 tab PO QD | 30 tabs · 3 refills | Sent to Pharmacy |
| Metformin HCl 1000 mg | Continued | 1 tab PO BID with meals | 60 tabs · 3 refills | Refilled |
| Atorvastatin 40 mg | Continued | 1 tab PO QHS | 30 tabs · 3 refills | Refilled |
| Referral To | Reason | Priority | Ordered | Status |
|---|---|---|---|---|
| Ophthalmology — Dr. R. Patel | Annual dilated retinal exam — DM | Routine | 03/15/2026 | Pending Auth |
| Diabetes Education Program | Dietary counseling / CDE referral | Routine | 03/15/2026 | Pending |
| Influenza Vaccine — In-Office | Annual immunization | Administered | 03/15/2026 | Complete |
| Medication | Dose / Route / Frequency | Indication | Prescriber | Last Refill | Status |
|---|---|---|---|---|---|
| Metformin HCl | 1000 mg PO BID with meals | Type 2 DM | Dr. Carter | 03/15/2026 | Active |
| Lisinopril ↑ Changed today | 20 mg PO QD (was 10 mg) | Hypertension | Dr. Carter | 03/15/2026 | Active |
| Amlodipine New today | 5 mg PO QD | Hypertension (add-on) | Dr. Carter | 03/15/2026 | Active |
| Atorvastatin | 40 mg PO QHS | Hyperlipidemia | Dr. Carter | 03/15/2026 | Active |
| Omeprazole | 20 mg PO QD before meals | GERD | Dr. Carter | 02/10/2026 | Active |
| Aspirin EC | 81 mg PO QD with food | CV prophylaxis | Dr. Carter | 01/20/2026 | Active |
| Medication | Dose | Reason Discontinued | Discontinued By | Date |
|---|---|---|---|---|
| Glipizide | 5 mg PO QD | Switched to Metformin — better glycemic profile | Dr. Carter | 08/2020 |
| Levothyroxine | 50 mcg PO QD | Hypothyroidism resolved — TSH normalized | Dr. Carter | 03/2022 |
| Hydrochlorothiazide | 12.5 mg PO QD | Replaced with Lisinopril — better renal protection for DM | Dr. Carter | 11/2022 |
| Study | Body Part / Modality | Indication | Ordered By | Date | Result | Status | |
|---|---|---|---|---|---|---|---|
🩻 | X-Ray Chest PA/Lateral | Chest · XR | HTN baseline · r/o cardiomegaly | Dr. Carter | 06/18/2025 | No acute cardiopulmonary process. Heart size normal. Lungs clear bilaterally. | Final |
🫀 | Echocardiogram (TTE) | Heart · Ultrasound | Evaluate cardiac function — longstanding HTN | Dr. Carter | 09/05/2025 | Mild LV diastolic dysfunction (Grade I). EF 58%. No wall motion abnormalities. Mild LVH noted. | Final |
👁️ | Dilated Retinal Exam | Eyes · Ophthalmology | Annual DM screening — overdue | Dr. Carter | 03/15/2026 | Referral placed — awaiting scheduling | Pending |
| CPT Code | Description | Units | Modifier | Amount |
|---|---|---|---|---|
| 99214 | Office E&M — Established, Moderate Complexity | 1 | — | $215.00 |
| 90686 | Influenza Vaccine — Quadrivalent, IM (administration) | 1 | — | $28.00 |
| 90656 | Influenza Vaccine — Supply | 1 | — | $18.50 |
| 83036 | Hemoglobin A1c (HbA1c) | 1 | — | $38.00 |
| 80053 | Comprehensive Metabolic Panel | 1 | — | $42.00 |
| 80061 | Lipid Panel | 1 | — | $36.00 |
| ICD-10 | Description | Type | Linked CPT |
|---|---|---|---|
| I10 | Essential (primary) hypertension | Principal | 99214 |
| E11.9 | Type 2 diabetes mellitus without complications | Principal | 99214 · 83036 |
| E78.5 | Hyperlipidemia, unspecified | Secondary | 80061 |
| E66.09 | Other obesity due to excess calories | Secondary | 99214 |
| Z23 | Encounter for immunization — Influenza | Secondary | 90686 · 90656 |